Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Pharmacyclics history
Pharmacyclics company history timeline
In 1998, a radically inventive biologist, J. Craig Venter, founded a company called Celera, with the goal of sequencing the human genome within three years.
The company’s attempts to try its hand at drug development -- kick-started by the acquisition of Axys Pharmaceuticals in 2001 -- had largely fallen short.
IDEC merged with Biogen in 2003.
According to public filings, Duggan began buying Pharmacyclics shares in the fall of 2004, when the company's stock was trading around $10 a share.
In another strange twist, Miller hasn’t been around to see this; he was reportedly forced out in 2008 by the chairman of the board, Robert Duggan, who is perhaps best known as Scientology’s biggest donor.
After a series of positive trials, J&J cut a deal in 2011 to co-promote Imbruvica for $975 million, and as the drug goes mainstream, Pharmacyclics caught the attention of large pharmaceutical firms looking for the next big treatment to put in their portfolios.
Rate how well Pharmacyclics lives up to its initial vision.
Pharmacyclics jobs
Do you work at Pharmacyclics?
Does Pharmacyclics communicate its history to new hires?
Pharmacyclics competitors
| Company name | Founded date | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Regeneron | 1988 | $14.2B | 9,123 | 386 |
| Seagen | 1997 | $2.0B | 900 | - |
| Acadia Pharmaceuticals | 1993 | $957.8M | 570 | 58 |
| Gilead Sciences | 1987 | $28.8B | 11,800 | 733 |
| Amgen | 1980 | $33.4B | 22,000 | 629 |
| Exelixis | 1994 | $2.2B | 484 | 172 |
| Merck | 1891 | $64.2B | 74,000 | 1,772 |
| Vertex Pharmaceuticals | 1989 | $11.0B | 3,400 | 284 |
| Ligand Pharmaceuticals | 1987 | $241.5M | 116 | - |
| Genentech | 1976 | $166.9M | 13,638 | 530 |
Pharmacyclics history FAQs
Zippia gives an in-depth look into the details of Pharmacyclics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Pharmacyclics. The employee data is based on information from people who have self-reported their past or current employments at Pharmacyclics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Pharmacyclics. The data presented on this page does not represent the view of Pharmacyclics and its employees or that of Zippia.
Pharmacyclics may also be known as or be related to PHARMACYCLICS INC, Pharmacyclics and Pharmacyclics LLC.